z-logo
open-access-imgOpen Access
Streptococcus agalactiae Toxic Shock-Like Syndrome
Author(s) -
Fadi Al Akhrass,
Lina Abdallah,
Steven C. Berger,
Rami Hanna,
Nina Reynolds,
Shellie Thompson,
Rabih Hallit,
Patrick M. Schlievert
Publication year - 2012
Publication title -
medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0b013e31827dea11
Subject(s) - toxic shock syndrome , streptococcus agalactiae , medicine , streptococcus , shock (circulatory) , mucocutaneous zone , microbiology and biotechnology , mortality rate , intensive care medicine , disease , staphylococcus aureus , bacteria , biology , genetics
We present 2 patients with Streptococcus agalactiae toxic shock-like syndrome and review another 11 well-reported cases from the literature. Streptococcal toxic shock-like syndrome is a devastating illness with a high mortality rate, therefore we stress the importance of early supportive management, antimicrobial therapy, and surgical intervention. Toxic shock-like syndrome is likely to be underestimated in patients with invasive Streptococcus agalactiae infection who present with shock. Early diagnosis requires high suspicion of the illness, along with a thorough mucocutaneous examination. Streptococcus agalactiae produces uncharacterized pyrogenic toxins, which explains the ability of the organism to cause toxic shock-like syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom